Journal
DRUG TESTING AND ANALYSIS
Volume 14, Issue 1, Pages 122-136Publisher
WILEY
DOI: 10.1002/dta.3151
Keywords
BMS-564929; GSK 2881078; metabolites; PF-0620414; TFM-4AS-1
Funding
- National Science Centre of Poland [2015/17/N/ST4/03923]
- European Regional Development Fund
Ask authors/readers for more resources
This study aimed to explore the metabolic pathways of four structurally unrelated SARMs and detect potential markers of intake of these substances through the analysis of their metabolites.
Selective androgen receptor modulators were developed as a treatment of choice for diseases that are currently treated or symtomatically treated with steroidal androgens. The present study aimed to explore the metabolic pathways of four structurally unrelated SARMs, namely, PF-06260414, TFM-4AS-1, BMS-564929, and GSK 2881078, in terms of their potential toxicology or doping control analysis. Detected metabolism, mainly resulting from a single or multiple hydroxylations, methoxylation, demethylation, dehydrogenation, and glucuronidation, was considered as potential markers of intake of examined SARMs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available